# Pipeline Activity Log

> **Review:** Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection  
> **Date:** 2026-03-26 00:51  
> **Duration:** 1h 54m  
> **Total tokens:** 436,843 (input: 399,047 / output: 37,796)

> **Review URL:** https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003508.pub2/full  
> **Dataset split:** HIV_test  
> **Studies:** 10  

## Resource Usage by Agent

| Agent | Steps | Time | Tokens (in / out) |
|-------|-------|------|-------------------|
| Orchestrator | 15 | 1h 54m | 149,525 / 8,382 |
| Librarian | 3 | 7m 49s | 10,574 / 3,107 |
| Gatekeeper | 4 | 21m 31s | 64,016 / 8,024 |
| Miner | 7 | 25m 09s | 54,818 / 9,634 |
| Critic | 9 | 22m 56s | 120,114 / 8,649 |
| **Total** | **38** | **1h 54m** | **399,047 / 37,796** |

---

## Activity Timeline

### 1. Planning (Orchestrator)

*01:04:42 — 13m 14s — 3,300 tokens*

The orchestrator analyzed the review protocol for cotrimoxazole prophylaxis in children with HIV to structure the workflow. It developed a multi-step strategy to delegate tasks, such as literature searching and eligibility screening, to specialized roles. This action produced a structured roadmap that guides the process from identifying studies to generating the final report.

---

### 2. Orchestrator → Librarian

*01:13:55 — 9m 12s — 19,774 tokens*

The orchestrator agent initiated the systematic review pipeline by instructing the librarian to search for studies matching the cotrimoxazole prophylaxis protocol. It provided the specific review objective and selection criteria for children with HIV infection to ensure a comprehensive search. The task concluded successfully with the retrieval of 10 candidate studies ready for screening.

> **Librarian — Step 1:** The librarian agent retrieved the systematic review protocol to establish the study's scope and eligibility criteria before initiating the literature search. This document outlines the goal of assessing cotrimoxazole prophylaxis in children with HIV infection and specifies the requirement for randomized trials involving young children or infants at risk. Successfully accessing this information ensures the agent has the necessary context to identify relevant candidate studies in the next phase.
> **Librarian — Step 2:** The librarian agent constructed a search query focusing on cotrimoxazole prophylaxis, HIV, and opportunistic infections in children to identify relevant randomised trials. It executed this search within the literature database and successfully located 10 candidate studies that align with the review protocol. These retrieved records, including titles and abstracts, are now available for further evaluation.
> **Librarian — Step 3 (result):** The librarian agent conducted a comprehensive search to identify randomized trials assessing cotrimoxazole prophylaxis for HIV-infected children and generated a final list of ten candidate studies. One trial involving Zambian children was identified as highly relevant to the review goals. The agent further highlighted that several other studies may require exclusion based on population age or study design.

---

### 3. Orchestrator → Gatekeeper

*01:36:46 — 22m 51s — 79,008 tokens*

The review pipeline screened ten candidate studies to determine eligibility for the systematic investigation of cotrimoxazole prophylaxis in children with HIV. The evaluation identified one trial that met the inclusion criteria, while nine studies were excluded based on the specific selection requirements. However, the automated step terminated before the results were fully processed because the task exceeded the maximum allowed execution time.

> **Gatekeeper — Step 1:** The gatekeeper agent screened 10 candidate studies to determine their eligibility for the systematic review. It evaluated each study against specific selection criteria, specifically looking for randomized trials comparing cotrimoxazole to placebo in children affected by HIV infection. This process identified which studies met the required population and intervention standards for inclusion.
> **Gatekeeper — Step 2:** The automated screening process evaluated ten candidate studies against criteria requiring randomised trials of cotrimoxazole prophylaxis in children with HIV. Each study was assessed for research design, participant age, and intervention type to determine suitability. Ultimately, one study satisfied all requirements and was included, while nine were excluded primarily due to adult populations or observational study designs.
> **Gatekeeper — Step 3:** The gatekeeper agent screened ten candidate studies against the review criteria for cotrimoxazole prophylaxis in children with HIV. One randomized controlled trial from Zambia was included because it met all population and intervention requirements, while nine studies were excluded. The excluded studies were rejected primarily for enrolling adult participants or using non-randomized observational designs.
> **Gatekeeper — Step 4 (result):** The automated screening process evaluated ten candidate studies to determine eligibility for the systematic review on cotrimoxazole prophylaxis in children with HIV. One study, the CHAP trial from Zambia, was included as the only randomized placebo-controlled trial meeting the specific criteria for children aged 1 to 14 years. The remaining nine studies were excluded primarily because they enrolled adult participants or utilized observational designs instead of randomized trials.

> ⚠️ **Error:** Code execution exceeded the maximum execution time of 500 seconds

---

### 4. Orchestrator → Miner

*01:43:16 — 6m 30s — 17,219 tokens*

The coordinating agent attempted to extract clinical evidence from the study identified during the screening phase. It instructed a specialized extraction agent to retrieve participant details, intervention data, and health outcomes for the review. However, the extraction failed because the study record was not successfully provided to the extraction agent, resulting in no data being captured.

> **Miner — Step 1:** The evidence extraction agent attempted to gather structured clinical data from the studies selected for this review on cotrimoxazole and HIV. Upon verifying the list of included studies, the agent found that none were currently available for processing. Consequently, the extraction process completed with zero studies processed.
> **Miner — Step 2 (result):** The evidence extraction agent attempted to compile structured details, such as participant characteristics and outcome measures, from the studies selected for the systematic review. However, it found that no study documents were provided in the current batch to analyze. Consequently, no data was generated, and the system reported that valid study text is required to proceed with the extraction.

---

### 5. Planning (Orchestrator)

*01:45:34 — 2m 17s — 4,918 tokens*

The orchestration agent assessed the current progress of the systematic review on cotrimoxazole prophylaxis for children with HIV. It verified that ten studies were retrieved and one met the criteria for inclusion. The agent has now planned the remaining steps to extract evidence, synthesize findings, and generate the final report.

---

### 6. Orchestrator (python_interpreter)

*01:47:04 — 1m 29s — 9,766 tokens*

The system identified that a study approved during screening was missing from the extracted results. It refreshed the study list and re-ran the extraction process to ensure data consistency. Although the attempt completed, no studies were successfully captured, confirming the issue persists.

---

### 7. Orchestrator (python_interpreter)

*01:48:23 — 1m 19s — 10,369 tokens*

The orchestrator detected that the study inclusion step unexpectedly returned no results and initiated a diagnostic review to identify the cause. It examined the content and structure of the candidate study list and screening decisions to verify the information was present and correctly formatted. This inspection confirmed the data was accessible, providing the necessary clarity to resolve the extraction issue.

---

### 8. Orchestrator (python_interpreter)

*01:49:49 — 1m 25s — 12,428 tokens*

The orchestrator detected that the automated system had failed to capture a study confirmed as eligible during the screening phase. It manually retrieved the title and abstract for the selected CHAP trial from the candidate list and organized the data for the next workflow step. This ensured that the single qualifying study was successfully passed forward for detailed data extraction.

---

### 9. Planning (Orchestrator)

*01:52:11 — 2m 22s — 7,349 tokens*

The orchestrator agent reviewed the systematic review protocol concerning cotrimoxazole prophylaxis for children with HIV infection. It confirmed that the initial literature search had successfully identified ten candidate studies eligible for further evaluation. Based on this status, the agent established a workflow plan to proceed with screening these studies, extracting data, and synthesizing the evidence into a final report.

---

### 10. Orchestrator → Miner

*02:14:41 — 22m 30s — 69,459 tokens*

The orchestrator tasked a specialized agent with extracting structured evidence from the CHAP trial to inform the systematic review on cotrimoxazole prophylaxis. The agent successfully retrieved key study details, including participant demographics and mortality outcomes, before the operation was halted. Despite exceeding the maximum time limit, the critical extraction results were captured prior to the interruption.

> **Miner — Step 1:** The agent extracted structured evidence from the included CHAP trial to support the systematic review on cotrimoxazole prophylaxis in children with HIV. It analyzed the study details to identify key participants, interventions, and outcomes such as mortality rates and adverse events. This process successfully captured quantitative findings, including hazard ratios and follow-up data, for inclusion in the review's evidence synthesis.
> **Miner — Step 2:** The agent sought to extract key clinical evidence from a study on cotrimoxazole use in HIV-infected children. When an initial automated approach did not provide sufficient detail, the agent re-processed the study abstract to capture specific study elements. This resulted in a structured summary of the research question, participants, and outcomes for the systematic review.
> **Miner — Step 3:** The miner agent reviewed the CHAP trial abstract to extract key study components, including the population, intervention, and primary outcomes. It captured specific effect measures for mortality and noted safety data regarding adverse events and neutropenia. The extracted information was successfully formatted into a standardized record for the systematic review.
> **Miner — Step 4:** The agent processed the Kazembe et al. 2004 trial to extract structured evidence regarding the study design, population, and clinical outcomes. It systematically captured details on the co-trimoxazole intervention versus placebo, including specific mortality rates and adverse event frequencies. This activity produced a verified summary confirming that the prophylaxis significantly reduced mortality in the study population without increasing serious adverse events.
> **Miner — Step 5 (result):** The miner agent successfully extracted structured evidence from the CHAP trial, capturing key details on the study population, intervention, and clinical outcomes. It generated a comprehensive final output that includes both a concise summary of findings and detailed statistical results regarding mortality and safety. This completes the extraction process, delivering formatted data ready for integration into the systematic review.

> ⚠️ **Error:** Code execution exceeded the maximum execution time of 500 seconds

---

### 11. Orchestrator (python_interpreter)

*02:16:22 — 1m 40s — 14,984 tokens*

The system confirmed that evidence extraction for the CHAP trial was complete, securing the finding that co-trimoxazole reduced mortality by 43%. Although the process experienced a processing delay, the data was successfully retrieved and verified as complete. The workflow has now progressed to the synthesis stage to validate and incorporate these findings into the review.

---

### 12. Orchestrator → Critic

*02:40:11 — 23m 49s — 143,958 tokens*

The orchestrator directed a specialized agent to synthesize the extracted evidence and assess study quality regarding cotrimoxazole prophylaxis in children with HIV. This analysis identified one high-quality trial demonstrating a significant reduction in mortality and concluded the overall evidence strength was strong. While the task execution was interrupted due to exceeding the processing time limit, the key synthesis findings were successfully generated and logged.

> **Critic — Step 1:** The agent intended to assess the methodological quality of the CHAP trial and synthesize the evidence for the review. It processed the study details to extract structured information but was unable to locate the necessary format within the text. Consequently, the automated quality assessment could not be completed, though the key trial outcomes remained accessible for review.
> **Critic — Step 2:** The agent attempted to organize the extracted evidence into a structured format to support quality assessment. It determined that the expected data structure was not present in the response. The available evidence was confirmed to be unstructured text summarizing trial outcomes regarding cotrimoxazole use in children with HIV.
> **Critic — Step 3:** The critic agent intended to structure the extracted evidence data to prepare it for quality assessment. However, the automated processing encountered a technical error that prevented the information from being validated. Consequently, the evidence synthesis was incomplete and requires reprocessing.
> **Critic — Step 4:** The agent synthesized the extracted data from the Kazembe et al. 2004 trial into a structured evidence record for evaluation. This summary consolidated key information regarding the HIV-infected pediatric population, co-trimoxazole prophylaxis intervention, mortality results, and adverse events. The evidence was successfully organized and verified, making it ready for the subsequent quality assessment process.
> **Critic — Step 5:** The critic agent assessed the methodological quality of the extracted evidence from the Kazembe et al. 2004 CHAP trial. It validated key study details, including the participant population in Zambia, the co-trimoxazole intervention, and associated mortality outcomes. This action successfully generated a quality assessment summary documenting the study design, statistical results, and adverse events for the systematic review.
> **Critic — Step 6:** The critic agent synthesized the extracted study data to address the research question concerning cotrimoxazole effects in children with HIV infection. It generated a structured summary detailing population characteristics, intervention specifics, and primary outcomes like all-cause mortality from the Kazembe et al. trial. This process created a clear evidence overview that supports the next stage of quality assessment.
> **Critic — Step 7:** The critic agent evaluated the methodological quality and synthesized findings from the CHAP trial regarding cotrimoxazole prophylaxis in children with HIV. It assigned a high quality rating with a low risk of bias, noting strengths like the randomized design alongside limitations such as the single-center setting. The final output provided a consolidated summary confirming a substantial mortality benefit and strong overall evidence strength.
> **Critic — Step 8:** The critic agent synthesized the extracted evidence to assess the quality and strength of findings regarding cotrimoxazole prophylaxis in HIV-infected children. It evaluated a single high-quality randomized trial and determined the evidence provides strong support for reducing mortality in children aged 1-14 years. The agent also noted significant evidence gaps regarding infants under one year and specific illness episodes beyond mortality.
> **Critic — Step 9 (result):** The agent completed the quality assessment and evidence synthesis for the systematic review on cotrimoxazole prophylaxis in HIV-infected children. After evaluating one high-quality randomized trial, it determined the evidence is strong, showing a significant reduction in mortality for children aged 1–14 years. The agent produced a final summary highlighting these benefits while documenting limitations such as the single geographic setting and gaps in data for infants.

> ⚠️ **Error:** Code execution exceeded the maximum execution time of 500 seconds

---

### 13. Planning (Orchestrator)

*02:42:47 — 2m 35s — 8,888 tokens*

The coordinating agent assessed the progress of the systematic review evaluating cotrimoxazole prophylaxis for children with HIV infection. It confirmed that the literature search and eligibility screening are complete, resulting in one included study out of ten candidates. The agent has now outlined the remaining workflow to extract data, synthesize the evidence, and produce the completed review report.

---

### 14. Orchestrator (python_interpreter)

*02:45:03 — 2m 16s — 17,311 tokens*

The orchestrator agent finalized the systematic review workflow by compiling all gathered data into a comprehensive final report. It integrated the review objective, search statistics, and detailed evidence summaries from included studies into a unified document. This action successfully generated a complete 7,092-character report assessing the effects of cotrimoxazole prophylaxis on children with HIV infection.

---

### 15. Final Output (Orchestrator)

*02:45:47 — 44s — 18,112 tokens*

The orchestrator finalized the systematic review pipeline by archiving the supporting evidence data and compiling the final report. This document outlines the review objective, screening results, and extracted findings from studies regarding cotrimoxazole prophylaxis for children with HIV infection. The process confirmed that all evidence was successfully stored before delivering the completed review to the user.

---
